Comparer des méthodes
Examinez les méthodes sélectionnées côte à côte ; les lignes qui diffèrent sont mises en évidence.
| Cancer Worry Scale× | EORTC QLQ-LC13 : Qualité de vie dans le cancer du poumon× | |
|---|---|---|
| Domaine | Oncologie | Oncologie |
| Famille | Process / pipeline | Process / pipeline |
| Année d'origine≠ | 1991 | 1994 |
| Auteur d'origine≠ | Lerman, C., et al. | Bergman, B., et al. (EORTC Quality of Life Group) |
| Type | Self-report questionnaire | Self-report questionnaire |
| Source fondatrice≠ | Lerman, C., Trock, B., Rimer, B. K., Jepson, C., Brody, D., & Boyce, A. (1991). Psychological side effects of breast cancer screening. Health Psychol, 10(1), 259–267. DOI ↗ | Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer, 30A(5), 635–642. DOI ↗ |
| Alias | CWS | QLQ-LC13 |
| Apparentées | 5 | 5 |
| Résumé≠ | The Cancer Worry Scale (CWS) is a brief 8-item instrument assessing the degree to which cancer-related worry interferes with daily functioning and emotional well-being. Developed by Lerman et al. in 1991, it quantifies cancer-related anxiety and distress—psychological burden distinct from symptom burden and functional impairment. It is widely used in cancer screening, treatment, and survivorship contexts to identify patients requiring psychological support. | The EORTC QLQ-LC13 is a 13-item lung-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire. Developed and validated by Bergman et al. in 1994, it measures lung-specific symptoms (dyspnea, cough, hemoptysis, chest pain) and treatment toxicities (sore mouth, dysphagia). It is the standard lung cancer-specific QoL instrument in European and international trials. |
| ScholarGateJeu de données ↗ |
|
|